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EXPERIMENTAL STUDIES - 
Effect of Ischemia and Postischemic Dysfunction on Myocardial 
Uptake of Technetium-99m-Labeled Methoxyisobutyl Isonitrile 
and Thallium-201 
ALBERT J. SINUSAS, MD, DENNY D. WATSON, PHD, JAMES M. CANNON, JR., ME, 
GEORGE A. BELLER, MD, FACC 
Charlottesville, Virginia 
The myocardial uptake of a new technetium-99m-labeled 
myocardial perfusion agent, methoxyisobutyl isonitrile 
(Tc-99m MIBI), and thallium-201 was correlated with 
microsphere flow in an open chest canine model of low 
coronary flow and postischemic dysfunction. Eighteen dogs 
were given an injection of thallium-201 (0.5 mCi) and 
Tc-99m MIBI (5 mCi) either after 40 min of partial left 
anterior descending artery occlusion (Group I, 10 dogs) or 
during reperfusion after 15 min of left anterior descending 
artery occlusion (Group II, 8 dogs). Regional dysfunction 
was documented during injection in both groups by quan- 
titative two-dimensional echocardiography. Regional blood 
flow was assessed by radiolabeled microspheres. The heart 
was excised 15 min after radionuclide injection and the left 
ventricle divided into 96 segments for gamma well count- 
ing. 
Among Group I dogs, central ischemic thallium-201 and 
Tc-99m MIBI activity (expressed as a percent of the activity 
Left ventricular dysfunction occurring in the absence of 
myocardial necrosis has been referred to as “stunned” 
(postischemic) or “hibernating” (chronic ischemic) myocar- 
dium (l-3). Although scintigraphic imaging with thallium-201 
provides a reasonable marker of myocardial viability (4), it 
may overestimate the degree of necrosis under conditions of 
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in the corresponding nonischemic zone) was comparable, 
respectively, for endocardial (54 + 17% and 52 f 17%), 
mid-wall (71 f 20% and 69 f 17%) and epicardial (89 f 
13% and 94 + 9%) segments and increased proportionally 
with flow. There was a good linear correlation among these 
endocardial segments between flow and both thallium-201 
(r = 0.78) and Tc-99m MIBI (r = 0.85) activity. Among 
Group II dogs, central ischemic endocardial flow (59 + 
14%) was comparable to thallium-201 (70 + 18%) and 
Tc-99m MIBI (74 f 12%) activity. Similarly, relative 
endocardial flow in the intermediate ischemic region (71 f 
11%) was comparable to thallium-201 (77 f 11%) and 
Tc-99m MIBI (81 f 10%) activity. 
Thus, myocardial uptake of Tc-99m MIBI and thallium- 
201 is comparable under conditions of low coronary flow 
and postischemic dysfunction and closely parallels flow 
alterations. 
(.I Am Co11 Cardiol1989;14:1785-93) 
ischemic or postischemic dysfunction (5). A new techne- 
tium-99m-labeled myocardial perfusion agent, methoxy- 
isobutyl isonitrile (Tc-99m MIBI), has been proposed as 
being better than thallium-201 for the assessment of myocar- 
dial perfusion and ischemia. The Tc-99m MIBI is a lipophilic 
cationic technetium-99m complex that, like thallium-201, is 
taken up by nonischemic and ischemic myocardium in 
proportion to regional myocardial blood flow (6-8). Prelim- 
inary in vitro studies (9) have shown that the myocardial 
uptake of Tc-99m MIBI may be influenced by metabolic 
conditions that simulate ischemia. Tc-99m MIBI binds with 
high affinity to a small molecular weight cytosolic protein; 
this binding is sensitive to severe hypoxia (10). 
The uptake kinetics of thallium-201 and Tc-99m MIBI 
have not been well defined under conditions of low coronary 
flow or in postischemic states in which flow has been 
restored to normal but left ventricular dysfunction persists. 
Myocardial imaging with a radionuclide agent that is sensi- 
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tive to metabolic disturbances and flow alterations would be 
valuable in identifying hibernating or stunned myocardium. 
Accordingly, the purpose of this investigation was to 
compare the myocardial uptake of thallium-201 and Tc-99m 
MIBI with flow in open chest canine models of low coronary 
flow and postischemic dysfunction. We postulated that Tc- 
99m MIBI might be a more sensitive marker than thallium- 
201 for detecting ischemia-induced myocardial metabolic 
abnormalities in vivo because uptake of Tc-99m MIBI in 
vitro is influenced by metabolic disturbances simulating 
ischemia. 
Methods 
Experimental preparation. Experiments were performed 
in 18 fasting adult mongrel dogs (mean weight 28.7 kg) 
anesthetized with intravenous sodium pentobarbital (30 
mg/kg body weight). The dogs were intubated and mechan- 
ically ventilated on a Harvard Apparatus respirator with 95% 
oxygen. A limb lead of the electrocardiogram was continu- 
ally monitored. A femoral vein was isolated and cannulated 
with an 8F polyethylene catheter for the administration of 
fluids, medication, Tc-99m MIBI and thallium-201. Both 
femoral arteries were isolated and cannulated with 8F poly- 
ethylene catheters for simultaneous withdrawal of micro- 
sphere reference samples, the withdrawal of blood for the 
determination of arterial pH, partial pressure of carbon 
dioxide (Pco~), partial pressure of oxygen (PO*) and contin- 
uous arterial pressure monitoring. A Swan-Ganz catheter 
was positioned in the pulmonary artery for the measurement 
of cardiac output and central temperature. 
Figure 1 illustrates the surgical preparation. A thoracot- 
omy was performed in the fifth intercostal space, and the 
heart was suspended in a pericardial cradle. The proximal 
portion of the left anterior descending coronary artery was 
then isolated, and a hydraulic occluder (model VO-3, 
Rhodes Medical Instruments) and an appropriately sized 
electromagnetic flow probe (Carolina Instruments) were 
placed around the vessel. A 22 gauge intravenous catheter 
(Jelco, Critikon) was inserted into a distal branch of the left 
anterior descending artery and connected to a Hewlett- 
Packard 1280 pressure transducer to continuously monitor 
the distal coronary pressure. A flared polyethylene tube was 
placed in the left atria1 appendage for pressure measurement 
and for injection of radiolabeled microspheres. A modified 
7F Sones brachial Al catheter (Cordis) was inserted through 
the external jugular vein and directed into the coronary sinus 
under direct visualization. The tip of this catheter was 
positioned at the origin of the great cardiac vein to measure 
coronary sinus lactate levels from the left anterior descend- 
ing perfusion territory. All experiments were performed with 
approval of the University of Virginia Animal Research 
Committee in compliance with the “Position of the Ameri- 
can Heart Association on Research Animal Use.” 
Left Atrial Pressure 
Caranary Flaw Robs 
Hydraulic Occludsr 
Figure 1. Illustration of the open chest canine model. The proximal 
left anterior descending (LAD) coronary artery was instrumented 
with an electromagnetic flow probe, hydraulic occluder and distal 
cannula for monitoring distal coronary pressure. The coronary sinus 
was cannulated with a catheter introduced through the external 
jugular vein. 
Postmortem myocardial analysis. At the end of the exper- 
iment, the dog was killed and the left ventricle and septum 
were separated from the remainder of the heart, trimmed of 
epicardial fat and vessels and divided into four slices from 
base to apex as previously described (11). The myocardial 
slices were incubated for 20 min at 38°C in a solution of 
2,3,5triphenyltetrazolium chloride (Sigma) and 0.2 molar 
Sorenson’s buffer. Each layer was then cut into eight trans- 
mural specimens, which were divided into epicardial, mid- 
wall and endocardial specimens. Five myocardial segments 
from the central left circumflex territory defined the non- 
ischemic normal zone. The ischemic zone was defined by 
endocardial flow values determined by radiolabeled micro- 
spheres as subsequently described. 
Determination of blood lactate. Blood samples were ob- 
tained by means of a polyethylene catheter positioned at the 
origin of the great cardiac vein. Blood was immediately 
placed on ice in a tube containing potassium oxalate and 
sodium fluoride. Serum lactate concentration was deter- 
mined by spectrophotometric analysis performed on an 
automated chemical analyzer (DuPont). 
Assessment of regional left ventricular function. Regional 
left ventricular function was evaluated by two-dimensional 
echocardiography. Echocardiographic images were obtained 
at the mid-papillary level using a 5 MHz transducer (Mark 
III, Advanced Technology Laboratory), and recorded on Yz 
inch (1.27 cm) videotape. Myocardial thickening was calcu- 
lated from short-axis images with an off-line analysis system 
(Mipron System, Kontron Electronics); it was derived from 
analysis of 64 equally spaced chords, extending from the 
epicardium to the endocardium, defined for end-diastolic and 
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end-systolic images. Thickening in the central ischemic and 
central nonischemic regions was determined from analysis of 
two centrally placed subsets of eight chords. 
Regional myocardial blood flow determination. The radio- 
labeled microsphere technique was used to assess regional 
myocardial blood flow (12). For each determination, 2 to 12 
million microspheres (8 to 10 pm diameter) were used. 
Myocardial samples were held for 2 weeks to permit de- 
cay of the thallium-201 and technetium-99m to appropriate 
levels to allow counting for microsphere activity. Sam- 
ples were counted in a Packard gamma autoscintillation 
counter. Separation of isotopes by energy windows (tin-l 13 
= 340 to 440 keV, ruthenium-103 = 450 to 570 keV, 
niobium-95 = 650 to 848 keV, scandium-46 = 850 to 1,300 
keV) was performed according to the method of Heymann 
et al. (12). 
Regional myocardial blood flow was expressed as mlimin 
per g. Ischemic flow was expressed as a percent of simulta- 
neous nonischemic flow to minimize variability due to the 
microsphere technique and to facilitate comparisons among 
dogs. 
Thallium-201 and Tc-99m MIBI activity determination. 
Normal and ischemic zone regional myocardial thallium-201 
and Tc-99m MIBI activity was determined by gamma well 
scintillation counting performed approximately 18 to 24 h 
after completion of the experimental protocol so that thal- 
lium-201 and Tc-99m MIBI myocardial activity would be 
similar. The Tc-99m MIBI was counted within a 130 to 190 
keV window and the thallium-201 within a 60 to 120 keV 
window. Activity spillover from one window to another for 
both radionuclides and the microspheres was corrected for 
with a matrix derived from pure specimens. Myocardial 
activity in the left anterior descending coronary artery 
territory was expressed as counts per gram and as a percent 
of corresponding normal left circumflex zone. 
Experimental Protocols 
Low coronary flow: Group I (Fig. 2A). After baseline 
steady state measurements, 10 dogs underwent 1 h of 
sustained partial left anterior descending artery occlusion. 
The hydraulic balloon occluder was adjusted throughout the 
period of stenosis to maintain distal left anterior descending 
artery pressure at approximately 50% of baseline value. 
Tc-99m MIBI (5 mCi) and thallium-201 (0.5 mCi) were 
injected after 40 min of low coronary flow. The dogs were 
killed within 20 min of injection of the radionuclide mixture 
to avoid thallium redistribution. The central temperature 
was maintained above 36°C with the acid of a heating pad 
and surgical lamps. Arterial blood was sampled at frequent 
intervals to assess pH, Pco, and PO,. Appropriate adjust- 
ments were made to maintain these variables in the physio- 
logic range. Coronary sinus lactate concentration was mea- 
sured under baseline conditions and after 15, 30 and 50 min 
- - -- 
2% 
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Figure 2. Schematic representation of experimental protocols, illus- 
trating the temporal sequence of coronary sinus lactate measure- 
ments, microsphere determination of flow, two-dimensional echo- 
cardiographic (ECHO) assessment of regional function and injection 
of Tc-99m MIBI and thallium-201 for both low coronary flow 
protocol (Group I) (A) and postischemic dysfunction protocol 
(Group II) (B). 
of low coronary flow. Regional function was assessed with 
two-dimensional echocardiography at baseline and after 20 
and 55 min of low coronary flow. Regional flow was assessed 
with radiolabeled microspheres at baseline study and at 
approximately 10 min after injection of the radionuclide 
mixture. 
Postiscbemic dysfunction: Group II (Fig. 2B). After base- 
line steady state measurements, eight dogs underwent 15 
min of total left anterior descending artery occlusion, fol- 
lowed by rapid reperfusion. Thallium-201 (0.5 mCi) and 
Tc-99m MIBI (5 mCi) were injected intravenously during 
reflow after the reactive hyperemia had resolved. The dogs 
were killed within 15 min of injection of the radionuclide 
mixture. Central temperature and arterial pH, Pco, and PO, 
were monitored as in Group I dogs, and appropriate adjust- 
ments made. Coronary sinus lactate was measured at base- 
line, during occlusion and after 5 and 10 min of reperfusion. 
Regional function was assessed with two-dimensional echo- 
cardiography at baseline, during occlusion and after 20 min 
of reperfusion. Radiolabeled microspheres were injected at 
baseline, during occlusion and after 25 min of reflow. 
Statistical methods. All computations were performed on 
a VAX computer. Data are expressed as mean values 5 1 
SD. Univariate analysis of mean data between groups was 
performed by either paired Student’s t test or one-way 
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analysis of variance (RS/l Bolt, Beraneck, Newman). Nor- 
mality of the distributions was verified with the Kolmog- 
orov-Smirnov test. Differences between groups were consid- 
ered significant at a p value of CO.05 (two-tailed). 
Results 
Among the 10 Group I dogs subjected to low flow 
ischemia, 4 had an inadequate reduction of microsphere flow 
during partial left anterior descending coronary artery occlu- 
sion. These four dogs had no more than one endocardial 
segment with stenotic flow 160% of baseline value, and 
were thus excluded from our analysis. In these dogs, flow 
measured with an electromagnetic flow probe was reduced 
by 38% and distal coronary pressure was reduced by 45%, 
suggesting increased collateral flow after establishment of 
the stenosis. One of the eight Group II dogs that underwent 
15 min of coronary occlusion and reflow was excluded from 
analysis because of fibrillation during reperfusion. A second 
dog was excluded because of technical problems related to 
the determination of microsphere flow. Thus, data were 
analyzed for six dogs in each group. 
Hemodynamics. Figure 3 illustrates the changes in heart 
rate, mean systemic arterial pressure, left anterior descend- 
ing artery pressure and left anterior descending artery flow 
measured with an electromagnetic flow probe for Group I 
dogs. The same hemodynamic variables for Group II dogs 
are shown in Figure 4. Heart rate and blood pressure 
remained constant throughout the experimental period for 
both groups of dogs. In Group I (low coronary flow), distal 
coronary pressure during the stenosis decreased by 54%, 
from 114 2 12 to 53 +- 9 mm Hg (p 5 0.0001). Baseline flow 
TIME Bin) 
Figure 3. Hemodynamics in Group I 
(mean values k 1 SD during baseline 
and partial left anterior descending 
[LAD] coronary artery occlusion 
[STENOSIS]). Arrows illustrate the 
timing of the intravenous injection of 
Tc-99m MIBI and thallium-201 (TL- 
201). 
measured with an electromagnetic flow probe was 37 -t 14 
mllmin and decreased to 25 + 13 mumin (p I 0.001) during 
occlusion, representing a 32% reduction in flow. In Group II 
(postischemic dysfunction), total occlusion of the left ante- 
rior descending artery resulted in a 70% decrease in distal 
coronary pressure, from 117 ? 18 to 35 ? 8 mm Hg (p I 
0.0001) (Fig. 4). After release of the occlusion, distal coro- 
nary pressure returned to 115 2 15 mm Hg (p = NS versus 
baseline). Flow measured with the electromagnetic flow 
probe was 30 5 4 mumin at baseline and decreased to 0 
mllmin during occlusion. A marked hyperemic response 
occurred with release of the occlusion, with peak flows 
approaching four times the baseline values. Thallium-201 
and Tc-99m MIBI were injected after 15 min of reflow when 
hyperemia had resolved (Fig. 4). 
Laboratory evaluation (Table 1). Arterial pH, PO, and 
Pco, remained relatively constant and within the physiologic 
range during both protocols. Average central body temper- 
ature remained >35”C. Cumulative laboratory data including 
central temperature, coronary sinus lactate concentration, 
arterial pH, PO, and Pco, for both Group I and Group II 
dogs are summarized in Table 1. The coronary sinus lactate 
concentration remained elevated after 15, 30 and 50 min of 
sustained low coronary flow in Group I dogs, but was more 
significantly elevated above baseline values in the Group II 
dogs, being 236% (p = 0.006) during occlusion, 236% 
(p = 0.01) at early reflow and 167% (p = 0.03) at late reflow. 
Histoebemical analysis. Histochemical staining of all 
myocardial slices with triphenyltetrazolium chloride in dogs 
in Groups I and II demonstrated no evidence of gross 
myocardial necrosis. 
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Figure 4. Hemodynamics in Group II 
(mean values ? I SD during baseline, 
left anterior descending [LAD] coro- 
nary artery occlusion [OCCI and 
reperfusion [REFLOW]). Thallium- 
201 (TL-201) and Tc-99m MIBI were 
injected intravenously after the reso- 
lution of the hyperemic response 
(arrows). 
Regional Systolic Function 
The changes in regional left ventricular function in the 
ischemic and nonischemic zones for both groups of dogs are 
illustrated in Figure 5. 
Group I. Myocardial thickening on echocardiography for 
the dogs in Group I with sustained low coronary flow did not 
change significantly in the nonischemic zone. There was a 
significant decrease in myocardial thickening with establish- 
ment of the stenosis in the ischemic zone relative to baseline 
study (Fig. 5A) after 20 min (p = 0.006) and 55 min (p = 0.01) 
of low flow. 
Table 1. Laboratory Evaluation 
Stenosis 
Baseline I5 min 30 min 50 min 
Group I: Low Coronary Flow 
Temperature (“C) 35.6 ? 1.3 36.2 + 1.0 35.7 ? 1.1 35.8 k 1.0 
CS lactate (mmoliliter) 2.1 2 I .6 2.4 2 1.3 2.4 2 1.2 2.3 k 1.1 
PH 7.33 t 0.06 7.34 + 0.06 7.35 2 0.04 7.35 t 0.06 
PO, (mm Hg) 121 5 16 144 + 46 131 + 50 128 ? 52 
Pco, (mm Hg) 35 t 7 37 + 5 35 t 6 36 + 6 
Group II: Postischemic Dysfunction 
Temperature (“C) 35.2 2 1.2 35.0 t 1.2 35.0 2 I.1 35.0 2 0.9 
CS lactate (mmoliliter) 0.7 f 0.4 1.6 +- 0.6* 1.6 t 0.6* 1.1 ? o.s* 
PH 7.42 ” 0.06 7.43 t 0.05 - 7.43 + 0.05 
I% (mm Hg) 114 ? 31 112 + 31 - 112 + 33 
Pco, (mm Hg) 30? 11 3321 - 32 5 8 
*p < 0.05 vs. baseline. CS = coronary sinus; Pcoz = partial pressure of 
carbon dioxide: Paz = partial pressure of oxygen. 
0 : : :A 
0 10 20 30 40 50 60 
TIME (ain) 
Group II. Thickening in the nonischemic zone in these 
dogs undergoing transient coronary occlusion and reflow did 
not change significantly from baseline during total occlusion 
or after reflow. There was a significant decrease in thicken- 
ing in the ischemic zone relative to baseline during occlusion 
Figure 5. Regional systolic function. Illustrated is echocardiographic 
myocardial thickening in the ischemic (hatched bars) and non- 
ischemic (open bars) zones for both Group I (A) and Group II (B) 
dogs. Thickening in the nonischemic zones in both groups did not 
significantly change. Thickening in the ischemic zone of dogs with 
low coronary flow remained significantly depressed at 20 and 55 min 
(A). Thickening in the postischemic zone was significantly de- 
creased during occlusion and reperfusion (B). 
A LOW CORONARY FLOW 
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Figure 6. Regional blood flow and myocardial activity in Group I. 
Open bars indicate stenotic flow levels among central ischemic 
segments expressed as a percent of corresponding nonischemic 
segmental flow. Myocardial thallium-201 (hatched bars) and Tc-99m 
MIBI (solid bars) activity levels, expressed as a percent of activity in 
nonischemic zones, were comparable and increased proportionally 
with flow. Among endocardial segments, relative thallium-201 ac- 
tivity was greater than flow (*p = 0.05 versus flow). 
0 20 40 a0 80 100 
FLOW (X non-ischemic) 
(p = O.Ol), with persistent regional postischemic dysfunction 
during reflow (p = 0.005) at the time of radionuclide injection 
(Fig. SB). 
Figure 7. Central ischemic endocardial activity versus flow in Group 
I. Illustrated is the correlation of thallium-201 (TL-201, open circles) 
and Tc-99m MIBI (closed triangles) activity and stenotic flow among 
those endocardial segments in which stenotic flow was reduced to 
560% of preocclusion flow. 
Regional Blood Flow and Thallium-201 and 
Tc-99m MIBZ Activity 
Group I. As expected with partial occlusion of the left 
anterior descending coronary artery, there was a transmural 
gradient in flow in the ischemic zone. A central ischemic 
zone was defined by those endocardial segments in which 
flow during stenosis was reduced to 160% of corresponding 
baseline flow measured by radiolabeled microspheres. This 
criterion defined 40 central ischemic segments among the six 
Group I dogs. Average endocardial flow in segments in the 
central ischemic zone was 0.40 + 0.16 mllmin per g, which 
was 39 + 10% of baseline flow and 35 2 12% of nonischemic 
endocardial flow after creation of the stenosis. Flow in the 
mid-wall and epicardia1 segments of the central ischemic 
zone was 0.58 ‘_ 0.23 and 0.84 + 0.29 mllmin per g, 
respectively. Flow in the nonischemic endocardial, mid-wall 
and epicardia1 segments during occlusion was 1.16 + 0.32, 
1.06 t 0.29 and 0.91 k 0.24 mllmin per g, respectively (p = 
NS versus baseline). 
Myocardial activity of thallium-201 and Tc-99m MIBI in 
the ischemic zone during low j7ow in Group I dogs is shown 
in Figure 6 as a percent of activity in the corresponding 
nonischemic zone. Both thallium-201 and Tc-99m MIBI 
myocardial activity decreased from the epicardium to the 
endocardium in the central ischemic zone. This decrease in 
myocardial activity relative to nonischemic activity was 
proportional to the transmural reduction in flow. In each 
region of the ischemic zone, the activity levels of thallium- 
201 and Tc-99m MIBI were comparable (p = NS). In the 
central ischemic endocardial region where flow was 35 + 
12% of that in the nonischemic zone, thallium-201 and 
Tc-99m MIBI activity was 54 5 17% and 52 k 17%, 
respectively, of nonischemic activity (Fig. 6). Endocardial 
activity tended to be higher for both thallium-201 (p = 0.05) 
and Tc-99m MIBI (p = 0.07) compared with flow values. 
However, there was a good linear correlation of activity 
versus flow among these 40 central ischemic endocardial 
segments for both thallium-201 (r = 0.78) and Tc-99m MIBI 
(r = 0.85) when values were expressed as a percent of 
nonischemic values (Fig. 7). 
Group II. Endocardial segments were segregated into 
central ischemic and intermediate ischemic zones on the 
basis of microsphere flow during coronary occlusion. The 
central ischemic zone was defined by the endocardial sam- 
ples in which flow during occlusion was ~30% of baseline 
flow. An intermediate zone was defined by those endocardial 
samples in which occlusion flow was >30% but ~60% of 
baseline flow. There were 29 central ischemic segments with 
an average endocardial flow during occlusion of 0.05 k 0.05 
ml/min per g. Mean flow in these central ischemic segments 
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Figure 8. Regional blood flow and myocardial activity in Group II. 
Illustrated are occlusion (vertically hatched bars) and reperfusion 
flows (open bars) and thallium-201 (diagonally hatched bars) and 
Tc-99m MIBI (solid bars) activity for central ischemic (n = 29) and 
intermediate ischemic (n = 21) endocardial segments expressed as a 
percent of nonischemic segmental flow. Both thallium-201 and 
Tc-99m MIBI activity levels were comparable with reperfusion flow 
in central and intermediate ischemic segments. 
was 0.55 t 0.06 ml/mm per g during reflow, at the time of 
radionuclide injection, which represented 79 k 19% of 
baseline flow and 59 2 14% of corresponding nonischemic 
flow, suggesting some degree of no reflow (Fig. 8). There 
were 21 intermediate endocardial segments with an average 
occlusion flow of 0.33 2 0.09 ml/min per g. Mean flow in the 
intermediate ischemic segments was 0.67 2 0.14 mllmin per 
g during reflow, which was 92 t 15% of baseline flow and 
71 lr 11% of corresponding nonischemic flow (Fig. 8). Flow 
in the nonischemic endocardial segments during occlusion 
and reflow was 0.97 + 0.27 and 0.99 2 0.29, ml/min per g, 
respectively; these values represented 111% and 114% of 
baseline flow. 
Myocardial uptake of thallium-201 and Tc-99m MIBI was 
comparable in both central (p = 0.63) and intermediate 
(p = 0.53) ischemic zones relative to nonischemic uptake. In 
the central ischemic endocardial segments where mean flow 
was reduced to 59 2 14% of nonischemic flow, myocardial 
activity of thallium-201 was reduced to 70 2 16% (p = 0.23) 
and Tc-99m MIBI activity to 74 4 12% (p = 0.07) of the 
corresponding nonischemic activity. The relative reduction 
in flow in the intermediate ischemic segments correlated 
with the reduction of thallium-201 activity to 77 c 11% 
(p = 0.35) and of Tc-99m MIBI uptake to 81 2 10% 
(p = 0.12) of corresponding nonischemic activity (Fig. 8). 
Among the 50 ischemic endocardial segments analyzed, 
there was a good linear correlation between flow and both 
thallium-201 (r = 0.69) and Tc-99m MIBI (r = 0.79) myocar- 
dial activity (Fig. 9). 
20 
t 
(TL-201) y - 0.69 + 29 r - 0.69 
I - + - IMIBI) y .63x 37 r - 0.79 
0, I 
0 20 40 00 00 100 
FLOW (X non-ie.chemic) 
Figure 9. lschemic endocardial activity versus reperfusion flow in 
Group II. Illustrated is the correlation of thallium-201 (TL-201, open 
circles) and Tc-99m MIBI (closed triangles) activity and reperfusion 
flow among those endocardial segments in which flow during occlu- 
sion was reduced to 560% of preocclusion flow. 
Discussion 
Myocardial uptake of Tc-99m MIBI versus thallium-201. 
We hypothesized that myocardial uptake of technetium- 
99m-labeled methoxyisobutyl isonitrile (Tc-99m MIBI) 
would be reduced to a greater degree than that of thallium- 
201 under ischemic conditions because preliminary in vitro 
studies suggested that Tc-99m MIBI extraction may be more 
sensitive to hypoxic conditions. The results of this study, 
however, show that the relative myocardial uptake values of 
Tc-99m MIBI and thallium-201 were comparable under 
conditions of low coronary flow and during reperfusion after 
15 min of coronary occlusion. These experimental models of 
ischemia produce myocardial systolic dysfunction that has 
been attributed to a persistent metabolic disturbance in the 
absence of necrosis. Under these conditions, myocardial 
uptake of both radionuclides in the ischemic region was 
directly proportional to microsphere flow at the time of 
radionuclide injection. Regional myocardial uptake of a 
diffusible tracer is dependent on both regional flow and 
myocardial extraction of the tracer. Although myocardial 
extraction of Tc-99m MIBI is less efficient than that of 
thallium-201 (13,14), we have shown that the relative uptake 
of both tracers is identical under physiologic flow conditions 
(0.04 to 0.91 ml/min per g). Thus, uptake of both radionu- 
elides is similarly affected by ischemic conditions producing 
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regional systolic dysfunction. Because we expressed uptake 
in the ischemic zones as a percent of nonischemic uptake, 
we did not necessarily expect to see differences in uptake 
between these tracers unless ischemic conditions affected 
uptake of the two radionuclides differently. 
Low coronary flow (“hibernating” myocardium). When 
coronary flow is significantly reduced, myocardial contrac- 
tile function will be impaired (IS), although viability of the 
tissue may be preserved. Chronic under-perfusion will pro- 
duce sustained myocardial dysfunction for as long as myo- 
cardial perfusion remains depressed. This condition, termed 
hibernating myocardium, has become clinically important 
because revascularization often results in improved left 
ventricular function (1). Rest and exercise thallium-201 
scintigraphy have been utilized to detect hibernating myo- 
cardium (16-18). We sought to gain a better understanding of 
the kinetics of Tc-99m MIBI under conditions of sustained 
low coronary flow produced by partial left anterior descend- 
ing artery occlusion. Relative myocardial uptake of both 
thallium-201 and Tc-99m MIBI in the ischemic region was 
comparable and increased proportionally with the transmu- 
ral flow gradient. There was a good linear correlation of 
relative myocardial activity and flow for thallium-201 and 
Tc-99m MIBI in the ischemic endocardial region. These 
findings suggest that during sustained low coronary flow 
producing left ventricular dysfunction without necrosis, thal- 
lium-201 and Tc-99m MIBI are similarly taken up in ischemic 
myocardium in proportion to flow. 
Although preliminary in vitro studies (9,lO) suggested 
that Tc-99m MIBI may be more influenced by metabolic 
disturbances than is thallium-201, we have demonstrated 
that uptake of both radionuclides is similar under conditions 
of low flow. Our findings are supported by preliminary data 
from Meerdink and Leppo (13) utilizing an isolated perfused 
rabbit heart. These investigators demonstrated no significant 
change in cardiac transport of Tc-99m MIBI or thallium-201 
when the heart was perfused with hypoxic buffer despite 
deterioration in mechanical performance. 
Myocardial tracer uptake in the central ischemic endocar- 
dial region relative to nonischemic uptake tended to be 
greater than relative flow for both thallium-201 (p = 0.05) 
and Tc-99m MIBI (p = 0.07). Previous investigators (19,20) 
have similarly shown increased myocardial uptake of thal- 
lium-201 relative to flow in very low flow regions as a result 
of the more efficient tissue extraction associated with a 
longer transit time (21). Li et al. (22) recently demonstrated 
a similar relation between microsphere flow and scinti- 
graphic Tc-99m MIBI uptake in the central ischemic region 
during a 6 min coronary artery occlusion. In that study, 
myocardial Tc-99m MIBI activity in the ischemic region 
consistently exceeded microsphere content when both val- 
ues were expressed as a fraction of nonischemic activity. 
Postischemic dysfunction (“stunned” myocardium). The 
delayed recovery of contractile function after 15 min of 
coronary occlusion and reflow (23-25) and multiple shorter 5 
min occlusions (26) has been previously demonstrated. The 
mechanism of this “myocardial stunning” is poorly under- 
stood. The mechanical dysfunction that persists after tran- 
sient ischemia limits the value of acutely assessing regional 
function as an index of myocardial viability during reperfu- 
sion. A 15 min coronary occlusion also results in transient 
biochemical alterations (24,27), ultrastructural changes of 
myocytes (24) and alterations in regional blood flow (28) that 
persist during reperfusion. Myocardial perfusion imaging 
that is sensitive both to metabolic disturbances and to flow 
alterations would be valuable in providing information rela- 
tive to myocardial viability under conditions of stunning 
where regional contractility is significantly reduced. 
Among the Group II dogs that underwent 15 min of 
coronary occlusion followed by reflow, there was a persist- 
ent 21% reduction in microsphere-determined flow in the 
central ischemic endocardial region 25 min after reperfusion, 
although coronary flow as measured by an epicardial flow 
probe had returned to baseline level. Heyndrickx et al. (28) 
previously demonstrated a similar reduction in microsphere 
flow 30 min after a 15 min coronary occlusion. In the present 
study, endocardial flow in the central ischemic region was 
59 2 14% of nonischemic flow, whereas thallium-201 and 
Tc-99m MIBI activities were comparable, respectively, at 
70 2 16% (p = 0.23) and 74 ? 12% (p = 0.07) of nonischemic 
activity after reperfusion. Endocardial thallium-201 and Tc- 
99m MIBI activity levels were also comparable in the 
intermediate ischemic zone and correlated closely with flow. 
Conclusions. Our data demonstrate that myocardial up- 
take of Tc-99m MIBI closely parallels that of thallium-201 
under conditions of low coronary flow and during the period 
of postischemic regional myocardial dysfunction. In our 
open chest canine models exhibiting these pathophysiologic 
conditions, uptake of both agents was directly proportional 
to flow. Although we have clearly shown that myocardial 
uptake of Tc-99m MIBI was similar to the initial uptake of 
thallium-201 under these ischemic conditions, further studies 
are necessary to determine if myocardial uptake of these 
radionuclides would differ under more severe ischemic con- 
ditions or in the presence of myocardial necrosis. 
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